356
Participants
Start Date
December 31, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
March 31, 2008
pregabalin
pregabalin 150-600 mg/day flexibly dosed for the first 6 weeks and fixed dosed for the last 2 weeks of total 8 weeks of double blind study period, + concurrent GAD treatment from the open-label study period
placebo
placebo + concurrent GAD treatment from the open-label study period
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, Pécs
Pfizer Investigational Site, Tallinn
Pfizer Investigational Site, Belgrade
Pfizer Investigational Site, Bala-Cynwyd
Pfizer Investigational Site, Media
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Baltimore
Pfizer Investigational Site, Columbia
Pfizer Investigational Site, Destin
Pfizer Investigational Site, Fort Walton Beach
Pfizer Investigational Site, Miami
Pfizer Investigational Site, South Miami
Pfizer Investigational Site, Kragujevac
Pfizer Investigational Site, Memphis
Pfizer Investigational Site, Memphis
Pfizer Investigational Site, Olive Branch
Pfizer Investigational Site, Beachwood
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Dnipropetrovsk
Pfizer Investigational Site, Dnipropetrovsk
Pfizer Investigational Site, Tartu
Pfizer Investigational Site, Saint Charles
Pfizer Investigational Site, Overland Park
Pfizer Investigational Site, Wichita
Pfizer Investigational Site, Omaha
Pfizer Investigational Site, Kuopio
Pfizer Investigational Site, Viljandi
Pfizer Investigational Site, Shreveport
Pfizer Investigational Site, Shreveport
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Lake Jackson
Pfizer Investigational Site, Lviv
Pfizer Investigational Site, Joensuu
Pfizer Investigational Site, Donetsk
Pfizer Investigational Site, Albuquerque
Pfizer Investigational Site, Luhansk
Pfizer Investigational Site, Sherman Oaks
Pfizer Investigational Site, Burbank
Pfizer Investigational Site, Redlands
Pfizer Investigational Site, Moscow
Pfizer Investigational Site, Moscow
Pfizer Investigational Site, Moscow
Pfizer Investigational Site, Saint Petersburg
Pfizer Investigational Site, Saint Petersburg
Pfizer Investigational Site, Saint Petersburg
Pfizer Investigational Site, Smolensk
Pfizer Investigational Site, Smolensk
Pfizer Investigational Site, Arcadia
Pfizer Investigational Site, Norwich
Pfizer Investigational Site, Boston
Pfizer Investigational Site, Clementon
Pfizer Investigational Site, New York
Pfizer Investigational Site, Cleveland
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Waukesha
Pfizer Investigational Site, Brno
Pfizer Investigational Site, Litoměřice
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Praha 8 - Bohnice
Pfizer Investigational Site, Helsinki
Pfizer Investigational Site, Belgrade
Pfizer Investigational Site, Belgrade
Pfizer Investigational Site, Kyiv
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY